NASDAQ NMS - GLOBAL MARKET · ILMN

+2.68% · +$4.26

Illumina Inc

Life Sciences Tools & Services

$162.96

+ Add to watchlist

Veridion Score

BETAMEDIUM CONF · 4/6 factors

As of May 30, 4:50 PM EDT · ILMN

Methodology

66/100

BUY BIAS

Composite intelligence score across six weighted factors. Higher score = stronger composite signal.

Score history: Coverage building

Institutional Flow · 90D

Corporate Insiders

SEC Form 4

30/ 100

-31.9M net shares (90d) · 37B / 18S

US Congress

Senate eFD + House STOCK Act

—/ 100

no data

Wall Street Analysts

Sell-side consensus

67/ 100

8 SB · 7 B · 10 H · 2 S · 1 SS

Sovereign · $25/mo

See why this score moved.

· Factor breakdown with raw signals
· Day-over-day delta + driver
· Factor coverage readout
· Insider · Congress · Wall Street flow
· Pro Chart event markers
· Score history + alerts

Start Sovereign · $25/mo →

Cancel anytime · or Reserve · $79/mo

Confidence: MEDIUM · 4/6 factors with data · Computed May 30, 4:50 PM EDT · Refreshes hourly

Share on X →

Veridion Score History · 90D

Composite trend over time

LOADING HISTORY…

REFRESHES DAILY

AI Analysis

BETA

Why is ILMN moving today?

Analyzing news articles + insider activity + analyst signals…

About Illumina Inc

LABORATORY ANALYTICAL INSTRUMENTS

Founded

—

Listed

2000

Employees

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Company website →

Open

$159.96

Previous close

$158.70

Day high

$165.37

Day low

$158.10

Market cap

$24.66B

IPO

2000-06-28

Country

Currency

USD

Data ledger

Quote and day range

As of May 29, 4:00 PM EDT

Source: Market data

Veridion Score

As of May 30, 4:50 PM EDT

Source: Veridion methodology

Chart and risk context

Daily bars with no missing-bar fill

Source: Market data

News and filings

Refresh intervals shown inside each panel

Source: Market news and federal filings

Financials

Loading quarterly statements…

Insider activity · 6M

Loading Form 4 filings…

Congress · 90D

Loading PTR filings…

Federal contracts

ILMN contract awards, year to date.

Public federal awards linked to this ticker.

$6.3M

Refresh interval: 12hSource: Federal contract awards

Department of Agriculture

$805.8K

PURCHASE OF 7 MISEQ I100S TO PERFORM WHOLE GENOME SEQUENCING (WGS) ON ALL FOODBORNE PATHOGENS ISOLATED AND CONFIRMED FROM FSIS INSPECTED PRODUCTS OFF USDA-WIDE CONTRACT 1232SA25D0004

PURCHASE OF 7 MISEQ I100S TO PERFORM WHOLE GENOME SEQUENCING (WGS) ON ALL FOODBORNE P...

Apr 28, 2026

Department of Health and Human Services

$544.7K

MAINTENANCE AND SERVICE CONTRACT FOR VARIOUS GOVERNMENT-OWNED ILLUMINA SEQUENCING PLATFORMS AND ANCILLARY EQUIPMENT

MAINTENANCE AND SERVICE CONTRACT FOR VARIOUS GOVERNMENT-OWNED ILLUMINA SEQUENCING PLA...

May 19, 2026

Department of Agriculture

$473.8K

LABORATORY CONSUMABLES

Feb 8, 2026

Department of Health and Human Services

$250.3K

ILLUMINA REAGENTS AND CONSUMABLES

Mar 2, 2026

Department of Health and Human Services

$248.3K

ILLUMINA REAGENTS AND CONSUMABLES FOR NCI

Mar 2, 2026

Lobbying spend

ILMN lobbying filings, year to date.

Registered lobbying filings matched to Illumina Inc.

$930.0K

Refresh interval: 12hSource: LDA disclosure filings

Budget/Appropriations Health Issues Homeland Security Medicare/Medicaid Trade (domestic/foreign)Health Issues Medicare/Medicaid Trade (domestic/foreign)Manufacturing Energy/Nuclear Taxation/Internal Revenue Code

Filing

$330.0K

ILLUMINA INC.

ILLUMINA, INC.

Jan 20, 2026

Filing

$320.0K

ILLUMINA INC.

ILLUMINA, INC.

Apr 20, 2026

Filing

$120.0K